Trial watch: dendritic cell vaccination for cancer immunotherapy

Author:

Sprooten Jenny1,Ceusters Jolien2,Coosemans An23,Agostinis Patrizia14,De Vleeschouwer Steven56,Zitvogel Laurence78910ORCID,Kroemer Guido1112131415ORCID,Galluzzi Lorenzo16171819ORCID,Garg Abhishek D.1ORCID

Affiliation:

1. Cell Death Research & Therapy (CDRT) unit, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium

2. Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, ImmunOvar Research Group, KU Leuven, Leuven Cancer Institute, Leuven, Belgium

3. Department of Gynecology and Obstetrics, UZ Leuven, Leuven, Belgium

4. Center for Cancer Biology (CCB), VIB, Leuven, Belgium

5. Research Group Experimental Neurosurgery and Neuroanatomy, KU Leuven, Leuven, Belgium

6. Department of Neurosurgery, UZ Leuven, Leuven, Belgium

7. Gustave Roussy Comprehensive Cancer Institute, Villejuif, France

8. INSERM, Villejuif, France

9. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France

10. Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France

11. Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France

12. Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France

13. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France

14. Suzhou Institute for Systems Medicine, Chinese Academy of Sciences, Suzhou, China

15. Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, Sweden

16. Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA

17. Sandra and Edward Meyer Cancer Center, New York, NY, USA

18. Department of Dermatology, Yale School of Medicine, New Haven, CT, USA

19. Université de Paris Descartes, Paris, France

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Cited by 110 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3